Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1492 (LINC01492) is a member of the long intergenic non-coding RNAs (lincRNAs), a subclass of long non-coding RNAs (lncRNAs) that are transcribed from genomic regions not overlapping protein-coding genes and typically longer than 200 nucleotides. LINC01492 does not encode a protein, and its specific biological role remains uncharacterized in the available literature. In general, lincRNAs are known to regulate gene expression through various mechanisms, including chromatin remodeling, transcriptional regulation, and modulation of neighboring gene activity, often in a tissue-specific manner. There is currently no evidence that LINC01492 is a validated or investigated therapeutic target, nor are there any known drugs, biomarker roles, or disease associations linked to this RNA in accessible databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1492 (LINC01492).